Article
Impact of Helicobacter pylori resistance to clarithromycin on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy.
Alimentary pharmacology & therapeutics - 1 May 2001
Tankovic J, Lamarque D, Lascols C, Soussy C J, Delchier J C
Abstract excerpt
BACKGROUND: Helicobacter pylori resistance to clarithromycin is relatively frequent in France and is assumed to be the main cause of failure of the proton pump inhibitor-amoxicillin-clarithromycin (proton pump inhibitor-AC) therapy, which is the first-line regimen in France. AIM: To determine the respective effects of clarithromycin primary and secondary resistances on efficacy of the proton pump inhibitor-AC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
